Correction: Bailey et al. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374

Simon Bailey*, Nicolas André, Lorenza Gandola, Maura Massimino, Keith Wheatley, Simon Gates, Victoria Homer, Stefan Rutkowski, Steven C. Clifford

*Corresponding author for this work

Research output: Contribution to journalComment/debate

10 Downloads (Pure)
Original languageEnglish
Article number1084
Number of pages2
JournalCancers
Volume16
Issue number6
DOIs
Publication statusPublished - 7 Mar 2024

Bibliographical note

Correction to Bailey, S.; André, N.; Gandola, L.; Massimino, M.; Wheatley, K.; Gates, S.; Homer, V.; Rutkowski, S.; Clifford, S.C. Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial. Cancers 2022, 14, 374. https://doi.org/10.3390/cancers14020374

Cite this